MILRINONE for Cerebral vasoconstriction: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where MILRINONE was used for Cerebral vasoconstriction.
Most Reported Side Effects for MILRINONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 360 | 42.4% | 57 | 202 |
| Off label use | 84 | 9.9% | 13 | 50 |
| Death | 64 | 7.5% | 64 | 4 |
| Hypotension | 55 | 6.5% | 13 | 23 |
| Condition aggravated | 54 | 6.4% | 10 | 25 |
| Drug ineffective for unapproved indication | 46 | 5.4% | 9 | 36 |
| Ventricular tachycardia | 41 | 4.8% | 4 | 27 |
| Cardiogenic shock | 34 | 4.0% | 7 | 27 |
| Cardiac arrest | 27 | 3.2% | 9 | 21 |
| Cardiac failure | 27 | 3.2% | 6 | 21 |
| Cardiomyopathy | 24 | 2.8% | 1 | 14 |
| Cardiac failure chronic | 23 | 2.7% | 0 | 20 |
| Therapy non-responder | 22 | 2.6% | 5 | 11 |
| Respiratory failure | 21 | 2.5% | 3 | 7 |
| Acute kidney injury | 20 | 2.4% | 4 | 14 |
Other Indications for MILRINONE
Product used for unknown indication (141)
Cardiac failure (115)
Cardiogenic shock (87)
Pulmonary hypertension (57)
Hypotension (30)
Cardiac failure congestive (22)
Shock (20)
Cardiomyopathy (19)
Left ventricular dysfunction (19)
Cardiac failure acute (17)